AIDS Virus Protection Gel Fails In African Trials
From MSNBC:
LONDON – U.S. drug firm Endo Pharmaceuticals’ gel designed to prevent infection with the AIDS virus has proved ineffective in trials in Africa, Britain’s Medical Research Council (MRC) said on Monday.
A large international trial of vaginal microbicide Pro 2000 in more than 9,000 women in four African countries found no evidence that it reduces the risk of HIV infection.
[ione_media_gallery legacy_id=”382352″ src=”https://newsone.com”%5D
The result is a setback for the specialty drugmaker, whose shares were hit earlier in the month when U.S. health regulators declined to approve its Aveed drug for low testosterone.
RELATED STORIES
HIV-Positive Husband Injects Sleeping Wife With Infected Blood
